Published Paper Details:

Title: Effectiveness of Half Somersault Maneuver Versus Semont Maneuver in BPPV Patient by Dix - Hallpike Test and Dizziness Handicapped Inventory Scale. Aim of the study: To Compare Half Somersault Maneuver versus Semont Maneuver in Patients with Posterior Canal Benign Paroxysmal Positional Vertigo (BPPV) Using the Dix-Hallpike Test and Dizziness Handicapped Inventory Scale aged 50-70 years. Methodology: Clinical diagnosis was confirmed using the Dix-Hallpike maneuver to provoke characteristic nystagmus. Therapeutic outcomes were assessed by comparing pre- and post-intervention scores via the Dizziness Handicapped Inventory (DHI) scale, a comprehensive 25-item self-assessment tool measuring functional, emotional, and physical disability. The standardized intervention protocol included one session per day involving three repetitions, performed five days weekly over a four-week duration. Design and setting: This research utilized a single-blinded comparative study design conducted over a six-month period within multi-specialty hospital settings. A cohort of 38 participants, aged between 50 and 70 years, was recruited and allocated into two equal groups of 19 through restricted randomization using a simple chit method. Result: Intragroup analysis using the Wilcoxon Signed Ranks Test showed that both the Half Somersault maneuver (median DHI score reduced from 46 to 30; p=0.000107) and the Semont maneuver (median DHI score reduced from 44 to 22; p=0.0001053) led to significant improvements. However, the between-group comparison via the Mann-Whitney U test yielded an extremely significant p-value (p=0.0000008817), indicating that the Semont maneuver produced a greater degree of improvement in reducing dizziness handicap compared to the Half Somersault maneuver. Conclusion: While both repositioning maneuvers are effective interventions for managing BPPV, the Semont maneuver is clinically superior to the Half Somersault maneuver in reducing dizziness-related disability and improving functional outcomes for patients in the 50-70 years age group.